KVX-478 VX-478 141W94 BDBM50215393 CHEBI:40050 Amprenavir 141 W94 Agenerase
BDBM577 VX-478 141W94 APV BDBM50215393 CHEMBL116 (3S)-oxolan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate Amprenavir Agenerase
- Rocheblave, L; Bihel, F; De Michelis, C; Priem, G; Courcambeck, J; Bonnet, B; Chermann, JC; Kraus, JL Synthesis and antiviral activity of new anti-HIV amprenavir bioisosteres. J Med Chem 45: 3321-4 (2002)
- Kovalevsky, AY; Ghosh, AK; Weber, IT Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir. J Med Chem 51: 6599-603 (2008)
- Yan, J; Huang, N; Li, S; Yang, LM; Xing, W; Zheng, YT; Hu, Y Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. Bioorg Med Chem Lett 22: 1976-9 (2012)